MIR4756: A Drug Target / Disease Biomarker (G100616225)
MIR4756: A Drug Target / Disease Biomarker
MIR4756 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes a family of transmembrane proteins that play important roles in various physiological processes. One of the functions of MIR4756 is to regulate the blood pressure, and it is suggested to be a potential drug target or biomarker for various cardiovascular diseases.
MIR4756 is involved in the regulation of sodium and water transport in the body. It is a component of the Na+/K+-ATPase, a protein that is responsible for maintaining the balance of sodium and potassium ions in the body. This ion transport mechanism is important for maintaining the resting membrane potential of the heart and for regulating the contractions of the smooth muscle in the walls of blood vessels. MIR4756 is also involved in the regulation of the production of new ATP by the creatine kinase, which is a critical enzyme involved in the process of cell signaling.
In addition to its role in ion transport and ATP production, MIR4756 is also involved in the regulation of cell signaling. It is a component of several signaling pathways that are important for the development and maintenance of various tissues and organs. For example, MIR4756 is a key component of the TGF-β pathway, which is involved in the regulation of cell growth and differentiation. It is also a component of the Wnt signaling pathway, which is involved in the regulation of cell growth and the development of various tissues.
MIR4756 is also of interest because it is suggested to be a potential drug target or biomarker for various cardiovascular diseases. The regulation of ion transport and cell signaling by MIR4756 is important for the development and maintenance of healthy cardiovascular tissues, and alterations in these processes have been implicated in the development of cardiovascular disease. For example, MIR4756 has been shown to be involved in the regulation of the growth and development of cardiomyocytes, which are the heart muscle cells that are responsible for maintaining the heart's electrical activity. It is also involved in the regulation of the expression of genes involved in cardiac fibrosis, which is the process by which the heart muscle becomes stiff and fibrotic.
In addition to its role in the regulation of ion transport and cell signaling, MIR4756 is also involved in the regulation of the blood pressure. It is a component of the Na+/K+-ATPase, which is responsible for maintaining the balance of sodium and potassium ions in the body. This ion transport mechanism is important for maintaining the resting membrane potential of the heart and for regulating the contractions of the smooth muscle in the walls of blood vessels. MIR4756 is also involved in the regulation of the production of new ATP by the creatine kinase, which is a critical enzyme involved in the process of cell signaling.
Overall, MIR4756 is a protein that is expressed in various tissues throughout the body that is involved in the regulation of ion transport, cell signaling, and blood pressure. Its involvement in these processes makes it a potential drug target or biomarker for various cardiovascular diseases. Further research is needed to fully understand the role of MIR4756 in these processes and to determine its potential as a drug or biomarker.
Protein Name: MicroRNA 4756
The "MIR4756 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4756 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091
